Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ProQR Therapeutics stock

Learn how to easily invest in ProQR Therapeutics stock.

ProQR Therapeutics NV is a biotechnology business based in the US. ProQR Therapeutics shares (PRQR) are listed on the NASDAQ and all prices are listed in US Dollars. ProQR Therapeutics employs 181 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in ProQR Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PRQR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

ProQR Therapeutics stock price (NASDAQ: PRQR)

Use our graph to track the performance of PRQR stocks over time.

ProQR Therapeutics shares at a glance

Information last updated 2022-07-01.
Latest market close$0.79
52-week range$0.53 - $9.09
50-day moving average $0.71
200-day moving average $4.18
Wall St. target price$2.39
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.96

Buy ProQR Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ProQR Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ProQR Therapeutics price performance over time

Historical closes compared with the close of $0.789 from 2022-07-01

1 week (2022-06-28) -0.50%
1 month (2022-06-01) N/A
3 months (2022-04-01) N/A
6 months (2022-01-04) -90.60%
1 year (2021-07-02) -87.88%
2 years (2020-07-02) -86.21%
3 years (2019-07-05) 9.23
5 years (2017-07-05) 5

ProQR Therapeutics financials

Revenue TTM $3.6 million
Gross profit TTM $2.4 million
Return on assets TTM -27.51%
Return on equity TTM -85.02%
Profit margin 0%
Book value $1.41
Market capitalisation $55.5 million

TTM: trailing 12 months

ProQR Therapeutics share dividends

We're not expecting ProQR Therapeutics to pay a dividend over the next 12 months.

ProQR Therapeutics share price volatility

Over the last 12 months, ProQR Therapeutics's shares have ranged in value from as little as $0.53 up to $9.09. A popular way to gauge a stock's volatility is its "beta".

PRQR.US volatility(beta: 0.96)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProQR Therapeutics's is 0.9614. This would suggest that ProQR Therapeutics's shares are less volatile than average (for this exchange).

ProQR Therapeutics overview

ProQR Therapeutics N. V. , a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc. , and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.

Frequently asked questions

What percentage of ProQR Therapeutics is owned by insiders or institutions?
Currently 7.777% of ProQR Therapeutics shares are held by insiders and 53.088% by institutions.
How many people work for ProQR Therapeutics?
Latest data suggests 181 work at ProQR Therapeutics.
When does the fiscal year end for ProQR Therapeutics?
ProQR Therapeutics's fiscal year ends in December.
Where is ProQR Therapeutics based?
ProQR Therapeutics's address is: Zernikedreef 9, Leiden, Netherlands, 2333 Ck
What is ProQR Therapeutics's ISIN number?
ProQR Therapeutics's international securities identification number is: NL0010872495
What is ProQR Therapeutics's CUSIP number?
ProQR Therapeutics's Committee on Uniform Securities Identification Procedures number is: N71542109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site